CYP-mediated drug metabolism from fetal life to adulthood
Pharmacological Research · 2026-12 · 234 · 109729
DOI: 10.1016/j.phrs.2026.109729 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmacological Research, 2026-12. Verfasst von Saba N Albetawi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Early Origins of Adult Health Research Group, Health and Biomedical Innovation, School of Pharmacy and Biomedical Sciences, Robinson Research Institu…. Die Arbeit nennt 223 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, Heart Foundation, Australian Research Council.
Abstract (Originalsprache)
Cytochrome P450 (CYP) enzymes metabolize ~80% of medications administered across the lifespan. Although CYP enzymes have been allocated to different ontogenic classes according to the developmental pattern of their hepatic protein expression, the roles of hormones, which coordinate developmental events and regulate nuclear receptors that control CYP gene expression, remain poorly understood. In addition, as most CYP enzymes have low expression and activity in the fetal liver, fetal CYP-mediated drug metabolism is largely dependent on CYP activity in the maternal liver and placenta. However, CYP activity changes across gestation in an isoform-specific manner, and it has been proposed that concentrations of pregnancy-related hormones (PRH) may be responsible for these changes. Moreover, there is a limited understanding of whether the maternal liver, placenta, and fetal liver respond differently to PRH, thus changing CYP activity during pregnancy in a tissue-specific manner. This review will describe the developmental changes in CYP enzyme expression and activity in the liver and the different regulatory mechanisms contributing to these changes. The current knowledge regarding changes in CYP enzyme expression and activity during pregnancy across the maternal-placental-fetal compartments, and the impact of PRH on the expression and activity of CYP enzymes, will be discussed.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Early Origins of Adult Health Research Group, Health and Biomedical Innovation, School of Pharmacy and Biomedical Sciences, Robinson Research Institute, College of Health, Adelaide University, North Terrace, Adelaide, S…
- Centre for Pharmaceutical Innovation, School of Pharmacy and Biomedical Sciences, College of Health, Adelaide University, North Terrace, Adelaide, SA 5001, Australia.
Förderung
- National Health and Medical Research Council
- Heart Foundation
- Australian Research Council
- Australian Government Department of Education
Zitieren
APA
Albetawi, S. N., Meakin, A. S., Wiese, M. D., & Morrison, J. L. (2026). CYP-mediated drug metabolism from fetal life to adulthood. Pharmacological Research, 234, 109729. https://doi.org/10.1016/j.phrs.2026.109729
Vancouver
Albetawi SN, Meakin AS, Wiese MD, Morrison JL. CYP-mediated drug metabolism from fetal life to adulthood. Pharmacological Research. 2026;234:109729. doi:10.1016/j.phrs.2026.109729
BibTeX
@article{Albetawi2026,
author = {Albetawi, Saba N and Meakin, Ashley S and Wiese, Michael D and Morrison, Janna L},
title = {CYP-mediated drug metabolism from fetal life to adulthood},
journal = {Pharmacological Research},
year = {2026},
volume = {234},
pages = {109729},
doi = {10.1016/j.phrs.2026.109729}
}
EUVIMED